Product Code: TIPRE00006881
The global colorectal cancer market is expected to reach US$ 22,953.8 Mn in 2027 from US$ 16,339.9 Mn in 2018. The market is anticipated to grow with a CAGR of 4.0% from 2019-2027.
Driving factors of the colorectal cancer are increasing prevalence of colorectal cancer, new product launches and benefits offered by generic drugs. Moreover, growing pharmaceutical industry in emerging economies is likely to have a positive impact on the growth of the market in the coming years.
Generic drugs are alternatives of branded drugs. The pharmacological effects of generic drugs are similar to their branded counterparts. Generic drugs are cost-effective as the manufacturers does not invest in the development and marketing a new drug. After the expiry of a drug patent, other manufacturers apply for FDA approval of a generic intended for its manufacturing and selling. Generic drugs are important in oncology due to the fact that some of the anticancer drugs are only offered as generics. Patients are likely seen to abandon branded prescriptions which are majorly associated with their higher co-pays. Among developing countries such as India, where the paying capacity is relatively low, generic drugs for cancer treatment acts as a boon for both the manufacturers as well as patients due to its affordability and efficacy. For instance, in June 2016, Hetero launched a Biosimilar 'Bevacizumab' for the treatment of metastatic colorectal cancer under the brand name "Cizumab". One of the most striking benefit of using generic drugs is the cost that is up to 85% less than that of the branded drugs.
The global colorectal cancer market, based on the modality, is segmented into diagnosis type, therapy type, and imaging type. In 2018, the diagnosis type segment held the largest market share of the colorectal cancer market. Based on the end user, market is segmented into hospitals, diagnostic and research laboratories. Hospitals segment is expected to dominate the end user segment during the forecast period.
Some of the important primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), American Society of Clinical Oncology, American Type Culture Collection, Centers for Disease Control and Prevention, National Colorectal Cancer Roundtable and others.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the colorectal cancer market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Global Colorectal Cancer Market - By Modality
- 1.3.2 Global Colorectal Cancer Market - By End User
- 1.3.3 Global Colorectal Cancer Market - By Geography
2. Colorectal Cancer Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Colorectal Cancer- Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 Colorectal Cancer Market - North America PEST Analysis
- 4.2.2 Colorectal Cancer Market - Europe PEST Analysis
- 4.2.3 Colorectal Cancer Market - Asia Pacific PEST Analysis
- 4.2.4 Colorectal Cancer Market - Middle East & Africa PEST Analysis
- 4.2.5 Colorectal Cancer Market - South And Central America PEST Analysis
- 4.3 Expert Opinion
- 4.4 Primary Care Physician And Practice Characteristics (US)
- 4.4.1 Practice Environment And Practice Patterns
- 4.4.2 US Census Region (Prevalence- 2018)
- 4.4.3 Typical Number Of Patients Per Week
- 4.4.4 CRC Screening Tests Ordered, Referred Or Performed Per Month
- 4.4.5 Number Of CRC Screening Modalities Recommended
- 4.5 Number Of Patients By Stage (US)
- 4.6 Number Of CEA Tests (US)
- 4.7 US Colorectal Cancer Prevalence- 2018
5. Colorectal Cancer- Key Dynamics
- 5.1 Key Drivers
- 5.1.1 Increasing Prevalence Of Colorectal Cancer
- 5.1.2 New Product Launches
- 5.1.3 Benefits Offered By Generic Drugs
- 5.2 Key Restraints
- 5.2.1 Pricing Pressure On Drug Manufacturers
- 5.3 Key Market Opportunities
- 5.3.1 Growing Pharmaceutical Industry In Emerging Economies
- 5.4 Future Trends
- 5.4.1 Inclination Towards Personalized Medicine
- 5.5 Impact Analysis
6. Colorectal Cancer Market - Global Analysis
- 6.1 Global Colorectal Cancer Market Revenue Forecasts And Analysis
- 6.2 Global Colorectal Cancer Market, By Geography - Forecasts And Analysis
- 6.3 Positioning Of Key Players
7. Colorectal Cancer Market Analysis And Forecasts To 2027 - Modality
- 7.1 Overview
- 7.2 Global Colorectal Cancer Market, By Modality 2018 & 2027 (%)
- 7.3 Diagnosis Type Market
- 7.3.1 Overview
- 7.3.2 Diagnosis Type Market Revenue and Forecast to 2027 (US$ Mn)
- 7.3.3 Immunohistochemistry Market
- 7.3.3.1 Overview
- 7.3.3.2 Immunohistochemistry Market Revenue and Forecast to 2027 (US$ Mn)
- 7.3.4 Stool Test Market
- 7.3.4.1 Overview
- 7.3.4.2 Stool Test Market Revenue and Forecast to 2027 (US$ Mn)
- 7.3.5 Flexible Sigmoidoscopy Market
- 7.3.5.1 Overview
- 7.3.5.2 Flexible Sigmoidoscopy Market Revenue and Forecast to 2027 (US$ Mn)
- 7.3.6 Colonoscopy Market
- 7.3.6.1 Overview
- 7.3.6.2 Colonoscopy Market Revenue and Forecast to 2027 (US$ Mn)
- 7.3.7 CEA Test Market
- 7.3.7.1 Overview
- 7.3.7.2 CEA Test Market Revenue and Forecast to 2027 (US$ Mn)
- 7.3.8 Other Test Market
- 7.3.8.1 Overview
- 7.3.8.2 Other Test Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4 Therapy Type Market
- 7.4.1 Overview
- 7.4.2 Global Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.4.3 Chemotherapy Market
- 7.4.3.1 Overview
- 7.4.3.2 Chemotherapy Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.3.3 Alkylating Agent Market
- 7.4.3.3.1 Overview
- 7.4.3.3.2 Alkylating Agent Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.3.4 Antimetabolites Market
- 7.4.3.4.1 Antimetabolites Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.3.5 Others Market
- 7.4.3.5.1 Others Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.4 Immunotherapy Market
- 7.4.4.1 Overview
- 7.4.4.2 Immunotherapy Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.4.3 Panitumumab Market
- 7.4.4.3.1 Overview
- 7.4.4.3.2 Panitumumab Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.4.4 Cetuximab Market
- 7.4.4.4.1 Overview
- 7.4.4.4.2 Cetuximab Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.4.5 Bevacizumab Market
- 7.4.4.5.1 Overview
- 7.4.4.5.2 Bevacizumab Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.4.6 Others Market
- 7.4.4.6.1 Overview
- 7.4.4.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.5 Chemoprotectant Market
- 7.4.5.1 Overview
- 7.4.5.2 Chemoprotectant Market Revenue and Forecast to 2027 (US$ Mn)
- 7.4.6 Others Market
- 7.4.6.1 Overview
- 7.4.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
- 7.5 Imaging Type Market
- 7.5.1 Overview
- 7.5.2 Global Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.5.3 Computed Tomography (CT) Market
- 7.5.3.1 Overview
- 7.5.3.2 Computed Tomography (CT) Market Revenue and Forecast to 2027 (US$ Mn)
- 7.5.4 Magnetic Resonance Imaging (MRI) Market
- 7.5.4.1 Overview
- 7.5.4.2 Magnetic Resonance Imaging (MRI) Market Revenue and Forecast to 2027 (US$ Mn)
- 7.5.5 Others Market
- 7.5.5.1 Overview
- 7.5.5.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
8. Global Colorectal Cancer Market Analysis- By End User
- 8.1 Overview
- 8.2 Global Colorectal Cancer Market, By End User 2018 & 2027 (%)
- 8.3 Hospitals Market
- 8.3.1 Overview
- 8.3.2 Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.4 Diagnostic and Research Laboratories Market
- 8.4.1 Overview
- 8.4.2 Global Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
9. Colorectal Cancer Market Revenue And Forecasts To 2027 - Geographical Analysis
- 9.1 North America Colorectal Cancer Market Revenue and Forecasts To 2027
- 9.1.1 Overview
- 9.1.2 North America Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.3 North America Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.1.3.1 North America Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.3.2 North America Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.3.2.1 North America Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.3.2.2 North America Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.3.3 North America Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.4 North America Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.1.5 North America Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
- 9.1.6 US Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.6.1 US Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.6.2 US Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.1.6.2.1 US Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.6.2.2 US Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.6.2.2.1 US Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.6.2.2.2 US Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.6.2.3 US Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.6.3 US Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.1.7 Canada Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.7.1 Canada Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.7.2 Canada Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.1.7.2.1 Canada Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.7.2.2 Canada Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.7.2.2.1 Canada Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.7.2.2.2 Canada Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.7.2.3 Canada Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.7.3 Canada Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.1.8 Mexico Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.8.1 Mexico Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.1.8.2 Mexico Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.1.8.2.1 Mexico Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.8.2.2 Mexico Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.8.2.2.1 Mexico Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.8.2.2.2 Mexico Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.8.2.3 Mexico Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.1.8.3 Mexico Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.2 Europe Colorectal Cancer Market Revenue and Forecasts To 2027
- 9.2.1 Overview
- 9.2.2 Europe Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.2.3 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.2.3.1 Europe Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.3.2 Europe Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.3.2.1 Europe Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.3.2.2 Europe Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.3.3 Europe Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.4 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.2.5 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
- 9.2.6 Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.2.6.1 Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.2.6.2 Germany Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.2.6.2.1 Germany Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.6.2.2 Germany Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.6.2.2.1 Germany Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.6.2.2.2 Germany Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.6.2.3 Germany Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.6.3 Germany Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.2.7 UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.2.7.1 UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.2.7.2 UK Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.2.7.2.1 UK Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.7.2.2 UK Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.7.2.2.1 UK Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.7.2.2.2 UK Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.7.2.3 UK Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.7.3 UK Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.2.8 France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.2.8.1 France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.2.8.2 France Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.2.8.2.1 France Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.8.2.2 France Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.8.2.2.1 France Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.8.2.2.2 France Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.8.2.3 France Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.8.3 France Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.2.9 Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.2.9.1 Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.2.9.2 Spain Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.2.9.2.1 Spain Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.9.2.2 Spain Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.9.2.2.1 Spain Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.9.2.2.2 Spain Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.9.2.3 Spain Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.9.3 Spain Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.2.10 Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.2.10.1 Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.2.10.2 Italy Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.2.10.2.1 Italy Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.10.2.2 Italy Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.10.2.2.1 Italy Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.10.2.2.2 Italy Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.10.2.3 Italy Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.2.10.3 Italy Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.3 Asia Pacific Colorectal Cancer Market Revenue and Forecasts To 2027
- 9.3.1 Overview
- 9.3.2 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.3.3 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.3.3.1 Asia Pacific Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.3.2 Asia Pacific Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.3.2.1 Asia Pacific Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.3.2.2 Asia Pacific Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.3.3 Asia Pacific Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.4 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.3.5 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
- 9.3.6 China Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.3.6.1 China Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.3.6.2 China Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.3.6.2.1 China Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.6.2.2 China Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.6.2.2.1 China Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.6.2.2.2 China Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.6.2.3 China Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.6.3 China Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.3.7 Japan Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.3.7.1 Japan Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.3.7.2 Japan Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.3.7.2.1 Japan Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.7.2.2 Japan Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.7.2.2.1 Japan Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.7.2.2.2 Japan Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.7.2.3 Japan Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.7.3 Japan Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.3.8 India Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.3.8.1 India Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.3.8.2 India Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.3.8.2.1 India Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.8.2.2 India Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.8.2.2.1 India Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.8.2.2.2 India Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.8.2.3 India Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.8.3 India Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.3.9 South Korea Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.3.9.1 South Korea Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.3.9.2 South Korea Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.3.9.2.1 South Korea Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.9.2.2 South Korea Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.9.2.2.1 South Korea Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.9.2.2.2 South Korea Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.9.2.3 South Korea Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.9.3 South Korea Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.3.10 Australia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.3.10.1 Australia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.3.10.2 Australia Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.3.10.2.1 Australia Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.10.2.2 Australia Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.10.2.2.1 Australia Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.10.2.2.2 Australia Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.10.2.3 Australia Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.3.10.3 Australia Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.4 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts To 2027
- 9.4.1 Overview
- 9.4.2 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.4.3 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.4.3.1 Middle East & Africa Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.3.2 Middle East & Africa Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.3.2.1 Middle East & Africa Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.3.2.2 Middle East & Africa Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.3.3 Middle East & Africa Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.4 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.4.5 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
- 9.4.6 UAE Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.4.6.1 UAE Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.4.6.2 UAE Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.4.6.2.1 UAE Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.6.2.2 UAE Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.6.2.2.1 UAE Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.6.2.2.2 UAE Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.6.2.3 UAE Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.6.3 UAE Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.4.7 Saudi Arabia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.4.7.1 Saudi Arabia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.4.7.2 Saudi Arabia Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.4.7.2.1 Saudi Arabia Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.7.2.2 Saudi Arabia Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.7.2.2.1 Saudi Arabia Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.7.2.2.2 Saudi Arabia Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.7.2.3 Saudi Arabia Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.7.3 Saudi Arabia Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.4.8 South Africa Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.4.8.1 South Africa Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.4.8.2 South Africa Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.4.8.2.1 South Africa Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.8.2.2 South Africa Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.8.2.2.1 South Africa Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.8.2.2.2 South Africa Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.8.2.3 South Africa Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.4.8.3 South Africa Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.5 South and Central America Colorectal Cancer Market Revenue and Forecasts To 2027
- 9.5.1 Overview
- 9.5.2 South and Central America Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.5.3 South and Central America Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.5.3.1 South and Central America Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.3.2 South and Central America Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.3.2.1 South and Central America Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.3.2.2 South and Central America Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.3.3 South and Central America Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.4 South and Central America Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.5.5 South and Central America Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
- 9.5.6 Brazil Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.5.6.1 Brazil Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.5.6.2 Brazil Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.5.6.2.1 Brazil Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.6.2.2 Brazil Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.6.2.2.1 Brazil Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.6.2.2.2 Brazil Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.6.2.3 Brazil Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.6.3 Brazil Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
- 9.5.7 Argentina Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.5.7.1 Argentina Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.5.7.2 Argentina Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
- 9.5.7.2.1 Argentina Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.7.2.2 Argentina Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.7.2.2.1 Argentina Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.7.2.2.2 Argentina Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.7.2.3 Argentina Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
- 9.5.7.3 Argentina Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10. Colorectal Cancer Market Industry Landscape
- 10.1 Overview
- 10.2 Growth Strategies In The Colorectal Cancer Market, 2016-2019
- 10.3 Organic Developments
- 10.3.1 Overview
- 10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2016-2019
- 10.4 Inorganic Developments
- 10.4.1 Overview
- 10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2016-2019
11. Colorectal Cancer Market-Key Company Profiles
- 11.1 Epigenomics AG
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Financial Overview
- 11.1.4 Product Portfolio
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 Novigenix SA
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Financial Overview
- 11.2.4 Product Portfolio
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 Clinical Genomics Technologies Pty Ltd.
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Financial Overview
- 11.3.4 Product Portfolio
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 EDP Biotech Corporation
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Financial Overview
- 11.4.4 Product Portfolio
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 Volitionrx Limited
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Financial Overview
- 11.5.4 Product Portfolio
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Abbott Laboratories
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Financial Overview
- 11.6.4 Product Portfolio
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 Amgen Inc.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Financial Overview
- 11.7.4 Product Portfolio
- 11.7.5 Pipeline (Clinical Trials) Portfolio
- 11.7.6 SWOT Analysis
- 11.7.7 Key Developments
- 11.8 F. Hoffmann-La Roche AG
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Financial Overview
- 11.8.4 Product Portfolio
- 11.8.5 Pipeline (Clinical Trials) Portfolio
- 11.8.6 SWOT Analysis
- 11.8.7 Key Developments
- 11.9 Bruker Corporation
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Financial Overview
- 11.9.4 Product Portfolio
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
- 11.10 Quest Diagnostics Incorporated
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Financial Overview
- 11.10.4 Product Portfolio
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
- 11.11 Natera, Inc.
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Financial Overview
- 11.11.4 Product Portfolio
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
- 11.12 Guardant Health, Inc.
- 11.12.1 Key Facts
- 11.12.2 Business Description
- 11.12.3 Financial Overview
- 11.12.4 Product Portfolio
- 11.12.5 SWOT Analysis
- 11.12.6 Key Developments
12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary of Terms
比較リスト
